1. In Vivo

CEO Interview: AstraZeneca's David Brennan

David Brennan has sharpened AstraZeneca's therapeutic area focus and embraced external R&D. The next two years will determine whether the productivity drive is working--or if more radical change is needed.

Melanie Senior

AstraZeneca PLC has proved its skills in the marketplace, with its top five drugs accounting for more than 50% of sales, and growing at 23% in 2006

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Global Vision

More from In Vivo